HACKENSACK MERIDIAN HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 2016-01-01
- Employees
- -
- Market Cap
- -
Dose Finding Study of Ibrutinib Plus Lenalidomide / Rituximab in Relapsed or Refractory Mantle Cell Lymphoma
Phase 1
Active, not recruiting
- Conditions
- Mantle Cell Lymphoma
- Interventions
- First Posted Date
- 2015-05-18
- Last Posted Date
- 2025-01-30
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 27
- Registration Number
- NCT02446236
- Locations
- 🇺🇸
The Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
TacTIC- Trans-disciplinary Chronic Disease Continuity of Care Model
Not Applicable
Withdrawn
- Conditions
- GeriatricsChronic Disease
- Interventions
- Behavioral: Standard of careBehavioral: TacTic care model
- First Posted Date
- 2015-03-26
- Last Posted Date
- 2018-08-08
- Lead Sponsor
- Hackensack Meridian Health
- Registration Number
- NCT02398851
- Locations
- 🇺🇸
Hackensack University Medical center, Hackensack, New Jersey, United States
The "Peripheral Access Utilizing Sonographic Evaluation" Study
Not Applicable
Withdrawn
- Conditions
- DIVA
- Interventions
- Device: ultrasound guided peripheral intravenous access (USGPIVA)Procedure: Traditional Landmark Technique (TLT)
- First Posted Date
- 2015-02-10
- Last Posted Date
- 2018-08-03
- Lead Sponsor
- Hackensack Meridian Health
- Registration Number
- NCT02360163
- Locations
- 🇺🇸
Hackensack University Medical center, Hackensack, New Jersey, United States
Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
- First Posted Date
- 2015-01-14
- Last Posted Date
- 2024-05-01
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 32
- Registration Number
- NCT02338232
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
The IMPROVE Study-IMPact of a Regulated ADC System
Completed
- Conditions
- Medication Administered in ErrorMedication Compliance
- First Posted Date
- 2014-08-29
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 120
- Registration Number
- NCT02228694
- Locations
- 🇺🇸
Hackensack University Medical center, Hackensack, New Jersey, United States
Pediatric Head Lice Study Product Comparison
Phase 2
Completed
- Conditions
- Head Lice
- Interventions
- Drug: LICEMDDrug: Standard Head lice product
- First Posted Date
- 2014-08-11
- Last Posted Date
- 2016-07-29
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 97
- Registration Number
- NCT02213055
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
Stem Cell Transplantation for Sickle Cell Anemia
Phase 3
Completed
- Conditions
- Sickle Cell Disease
- Interventions
- First Posted Date
- 2013-06-14
- Last Posted Date
- 2022-11-07
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 30
- Registration Number
- NCT01877837
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
Correlation Between CPAP Compliance and Food Intake Timing
Completed
- Conditions
- Obstructive Sleep Apnea
- First Posted Date
- 2013-05-13
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 50
- Registration Number
- NCT01851811
- Locations
- 🇺🇸
Hackensack University Medical Center, Hackensack, New Jersey, United States
Preparing Caregivers for the Child Sexual Abuse Examination: Are Informational Leaflets Helpful?
Not Applicable
Completed
- Conditions
- Child Sexual Abuse, Suspected
- Interventions
- Behavioral: Education Counseling
- First Posted Date
- 2013-05-09
- Last Posted Date
- 2014-02-04
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 37
- Registration Number
- NCT01850407
A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531
Phase 2
Completed
- Conditions
- Waldenstrom Macroglobulinemia
- Interventions
- First Posted Date
- 2013-03-18
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Hackensack Meridian Health
- Target Recruit Count
- 7
- Registration Number
- NCT01813227
- Locations
- 🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
© Copyright 2025. All Rights Reserved by MedPath